Publicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (84)

2024

  1. Cardiovascular risk assessment: Missing albuminuria contributing to gender inequality

    Nefrologia

  2. Consensus on the Approach to Hydrosaline Overload in Acute Heart Failure. SEMI/SEC/S.E.N. Recommendations

    Revista Espanola de Cardiologia

  3. Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain

    Nefrologia

  4. Genetic study in young patients with chronic kidney disease stage G5 from unknown etiology. The GENSEN study design

    Nefrologia

  5. Hacia la estandarización de la formación de PoCUS en nefrología: el momento es ahora

    Nefrologia, Vol. 44, Núm. 1, pp. 5-9

  6. Impact of pruriture associated with chronic renal disease (PaCKD) on the quality of life of patients in hemodialysis in Spain

    Nefrologia

2023

  1. Acute renal failure due to rhabdomyolysis in relation to abiraterone and rosuvastatin

    Nefrologia

  2. Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain

    Nefrologia, Vol. 43, Núm. 6, pp. 721-730

  3. Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 4, pp. 969-981

  4. Impact of pruriture associated with chronic renal disease (PaCKD) on the quality of life of patients in hemodialysis in Spain

    Nefrologia, Vol. 43, Núm. 6, pp. 663-667

  5. La enfermedad renal crónica, una epidemia silenciosa

    RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 8, Núm. 2, pp. 3-10

  6. Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum

    Nefrologia

  7. Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum

    Nefrologia, Vol. 43, Núm. 6, pp. 676-687

  8. New mechanisms involved in the development of cardiovascular disease in chronic kidney disease

    Nefrologia, Vol. 43, Núm. 1, pp. 63-80

  9. Reticulocyte hemoglobin content and iron therapy in chronic kidney disease: Reply of the Anemia group of the Spanish Society of Nephrology

    Nefrologia

  10. Reticulocyte hemoglobin content and iron therapy in chronic kidney disease: Response of the Anemia group of the Spanish Society of Nephrology

    Nefrologia

  11. The Spanish Scientific Societies before the ESC 2021 guidelines on vascular disease prevention: Generalizing the measurement of albuminuria to identify vascular risk and prevent vascular disease

    Nefrologia, Vol. 43, Núm. 2, pp. 245-250

  12. Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration

    Clinical Kidney Journal, Vol. 16, Núm. 11, pp. 2254-2261

  13. Unresolved aspects in the management of renal anemia, a Delphi consensus of the Anemia Group of the S.E.N

    Nefrologia, Vol. 43, Núm. 5, pp. 517-530

  14. Update of the prevention and isolation measure recommendations against SARS-COV-2 in dialysis units of Spain: A position paper of the Spanish Society of Nephrology Council

    Nefrologia